Likewise, in the in vivo mouse xenograft study, the group of mice injected with HPAF-II/SLC38A5/CRISPR KO cells had a significant reduction in tumor volume when compared to the group injected with HPAF-II/NTC cells (Fig. 4E). The gene discussed is SLC38A5; the disease is neoplasm.